834769

Osiris Therapeutics Inc — FEI 3006638648

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 4, 2013
Fiscal Year
2013
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Columbia, MD (United States)